PL314036A1 - Pharmaceutical composition - Google Patents

Pharmaceutical composition

Info

Publication number
PL314036A1
PL314036A1 PL94314036A PL31403694A PL314036A1 PL 314036 A1 PL314036 A1 PL 314036A1 PL 94314036 A PL94314036 A PL 94314036A PL 31403694 A PL31403694 A PL 31403694A PL 314036 A1 PL314036 A1 PL 314036A1
Authority
PL
Poland
Prior art keywords
pharmaceutical composition
pharmaceutical
composition
Prior art date
Application number
PL94314036A
Other languages
English (en)
Inventor
Kenneth Donald Vaughan
Original Assignee
Boots Co Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB939321671A external-priority patent/GB9321671D0/en
Priority claimed from GB9405025A external-priority patent/GB9405025D0/en
Priority claimed from GB9405024A external-priority patent/GB9405024D0/en
Application filed by Boots Co Plc filed Critical Boots Co Plc
Publication of PL314036A1 publication Critical patent/PL314036A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PL94314036A 1993-10-20 1994-10-19 Pharmaceutical composition PL314036A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB939321671A GB9321671D0 (en) 1993-10-20 1993-10-20 Pharmaceutical composition
GB9405025A GB9405025D0 (en) 1994-03-15 1994-03-15 Pharmaceutical composition
GB9405024A GB9405024D0 (en) 1994-03-15 1994-03-15 Pharmaceutical composition

Publications (1)

Publication Number Publication Date
PL314036A1 true PL314036A1 (en) 1996-08-05

Family

ID=27266892

Family Applications (1)

Application Number Title Priority Date Filing Date
PL94314036A PL314036A1 (en) 1993-10-20 1994-10-19 Pharmaceutical composition

Country Status (11)

Country Link
EP (1) EP0724438A1 (cs)
JP (1) JPH09504018A (cs)
AU (1) AU690155B2 (cs)
CA (1) CA2174619A1 (cs)
CZ (1) CZ112496A3 (cs)
FI (1) FI961716A (cs)
HU (1) HUT74448A (cs)
NO (1) NO961589L (cs)
PL (1) PL314036A1 (cs)
SK (1) SK48896A3 (cs)
WO (1) WO1995011017A1 (cs)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9606429D0 (en) * 1996-03-27 1996-06-05 Boots Co Plc Pharmaceutical compositions
DK0897726T3 (da) * 1996-11-25 2007-08-13 Toray Industries Antipruritisk middel
AU2006228869A1 (en) 2005-03-30 2006-10-05 Astion Pharma A/S Oxaprozin or a closely related compound for the treatment of eczema
EP2244703B1 (de) * 2007-12-21 2011-09-28 Horizon Pharma AG Arzneimittel sowie deren herstellung und verwendung bei der behandlung von schmerzhaften neuropathien
CA2784827C (en) * 2009-12-16 2018-10-23 Shasun Pharmaceuticals Limited Composition of dexibuprofen transdermal hydrogel
EP2468270A1 (en) 2010-12-21 2012-06-27 GALENpharma GmbH (R)-2-(3-fluoro-4-phenylphenyl)propionic acid for use in the treatment of skin diseases
GB2493914A (en) * 2011-08-19 2013-02-27 Univ Jw Goethe Frankfurt Main Flurbiprofen and related compounds for the treatment of skin diseases
CN113262216A (zh) * 2020-02-14 2021-08-17 北京泰德制药股份有限公司 一种用于消除皮表红肿镇痛的外用制剂
WO2024101489A1 (ko) * 2022-11-11 2024-05-16 주식회사 지케이랩 가려움증 치료제에 쓰일 수 있는 프로피온산계 비스테로이드성 약물을 유효성분으로 함유하는 외용 겔 제제의 제조법

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2075837B (en) * 1980-05-14 1984-03-14 Hisamitsu Pharmaceutical Co Topical pharmaceutical gel containing anti-inflammatory analgesic agents
DE3317124A1 (de) * 1983-05-07 1984-11-08 Teroson Gmbh, 6900 Heidelberg Vorrichtung zum auftragen von fluessigkeiten mit unterschiedlicher konsistenz
JPS59222409A (ja) * 1983-06-01 1984-12-14 Nippon Redarii Kk 消炎鎮痛ゲル軟膏剤
JPH0735330B2 (ja) * 1986-03-12 1995-04-19 久光製薬株式会社 外用クリ−ム組成物
JPH01224328A (ja) * 1988-03-01 1989-09-07 Kao Corp 鎮痒剤組成物
US5093133A (en) * 1990-01-24 1992-03-03 Mcneil-Ppc, Inc. Method for percutaneous delivery of ibuprofen using hydroalcoholic gel

Also Published As

Publication number Publication date
HUT74448A (en) 1996-12-30
AU8058694A (en) 1995-05-08
CZ112496A3 (en) 1997-04-16
NO961589D0 (no) 1996-04-19
FI961716A0 (fi) 1996-04-19
FI961716A (fi) 1996-06-03
JPH09504018A (ja) 1997-04-22
SK48896A3 (en) 1997-03-05
WO1995011017A1 (en) 1995-04-27
EP0724438A1 (en) 1996-08-07
AU690155B2 (en) 1998-04-23
HU9601031D0 (en) 1996-06-28
CA2174619A1 (en) 1995-04-27
NO961589L (no) 1996-06-17

Similar Documents

Publication Publication Date Title
HU9402974D0 (en) Pharmaceutical composition
GB9317686D0 (en) Pharmaceutical compositions
ZA945930B (en) Pharmaceutical composition
GB9317610D0 (en) Pharmaceutical compositions
GB2272375B (en) Pharmaceutical composition
PL314036A1 (en) Pharmaceutical composition
CA2100836A1 (en) Pharmaceutical composition
GB9317504D0 (en) Pharmaceutical compositions
ZA945752B (en) Pharmaceutical composition
GB9221707D0 (en) Pharmaceutical composition
GB9318880D0 (en) Pharmaceutical composition
HU9401771D0 (en) Pharmaceutical compositions cintaining ipsapiron
GB9420129D0 (en) Pharmaceutical compositions
ZA947913B (en) Pharmaceutical composition
GB9417021D0 (en) Pharmaceutical composition
GB9318350D0 (en) Pharmaceutical composition
GB9314709D0 (en) Pharmaceutical composition
ZA935269B (en) Pharmaceutical composition
GB9308849D0 (en) Pharmaceutical composition
GB9320688D0 (en) Pharmaceutical composition
GB9321671D0 (en) Pharmaceutical composition
HU9303511D0 (en) Pharmaceutical composition
HU9303386D0 (en) Pharmaceutical composition
GB9314564D0 (en) Pharmaceutical composition
GB9311058D0 (en) Pharmaceutical compositions